文献速递肥胖与代谢综合征性腺与生殖内分泌垂体与肾上腺疾病

非综合征性儿童肥胖的类固醇代谢组学疾病特征

Steroid Metabolomic Disease Signature of Nonsyndromic Childhood Obesity.
PubMed 文献 · J Clin Endocrinol Metab · 2016-08-09

研究对87例8.5-17.9岁肥胖儿童(44例女性)的24小时尿用气相色谱-质谱法定量31种类固醇代谢物,经k-means聚类分为5组,各组具有不同的类固醇代谢组学特征,但组间BMI的z值无显著差异。

要点

  • 聚类1(n=39,21例女性)类固醇谱正常。
  • 聚类3(n=7,均为女性)相对21-羟化酶不足,表现为部分或完全多囊卵巢综合征。
  • 聚类4(n=4,均为男性)C21类固醇显著升高、11β-羟类固醇脱氢酶系统失衡,胰岛素更高、糖/胰岛素指数大于0.3的频率增加、γ-谷氨酰转肽酶活性及收缩压升高,并有肝脂肪变性倾向。

核心结论

  • 作者提出基于尿液类固醇气相色谱-质谱法的疾病特异性类固醇代谢组学特征新概念,通过聚类将儿童肥胖重新分类为5个具有不同特征的组,各组尚需进一步定义,并可能需要针对不同聚类的治疗策略。

研究设计与样本

  • 共87例肥胖儿童(44例女性),年龄8.5-17.9岁,进行临床特征评估并收集24小时尿。
  • 用气相色谱-质谱法定量31种类固醇代谢物,排泄率经z转换,使用MetaboAnalyst 3.0以k-means聚类将受试者分为5组。

主要发现

  • 聚类1(n=39,21例女性)类固醇谱正常。
  • 聚类2(n=20,11例女性)显示C19和C21类固醇轻度非特异性升高,女性对多囊卵巢形态有抵抗,并有多毛。
  • 聚类3(n=7,均为女性)伴相对21-羟化酶不足,表现为部分或完全多囊卵巢综合征。
  • 聚类4(n=4,均为男性)显示C21类固醇显著升高、11β-羟类固醇脱氢酶系统失衡,胰岛素更高、糖/胰岛素指数大于0.3的频率增加、γ-谷氨酰转肽酶活性及收缩压升高,并有肝脂肪变性倾向。
  • 聚类5(n=17,5例女性)脱氢表雄酮和17-OH-孕烯醇酮代谢物升高,提示3β-羟类固醇脱氢酶不足,但无临床独特表型。

关键数值与推荐

  • 各聚类间BMI的z值无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 各组尚需进一步定义,并可能需要针对不同聚类的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The profile of urinary steroids as measured by gas chromatography-mass spectrometry defines a subject's "steroidal fingerprint." OBJECTIVE: Here, we clustered steroidal fingerprints to characterize patients with nonsyndromic childhood obesity by "steroid metabolomic signatures." HYPOTHESIS: Nonsyndromic obesity is a symptom of different diseases and conditions, some of them will have their own signature. DESIGN: A total of 31 steroid metabolites were quantified by gas chromatography-mass spectrometry, and their excretion rates were z-transformed. Using MetaboAnalyst 3.0, we divided the subjects into 5 distinctive groups by k-means clustering. Steroidal fingerprints and clinical/biochemical data of patients in each cluster were analyzed. PATIENTS: A total of 87 obese children (44 females), aged 8.5-17.9 years, were clinically characterized, and their 24-hour urine was collected. RESULTS: Cluster 1 (n = 39, 21 females) had normal steroid profile. Cluster 2 (n = 20, 11 females) showed mild, nonspecific elevation of C19 and C21 steroids, females' resistance to polycystic ovary morphology, and hirsutism. Cluster 3 (n = 7 female), with relative 21-hydroxylase insufficiency, was characterized by partial or full polycystic ovary syndrome. Cluster 4 (n = 4 males), showed markedly elevated C21 steroids and imbalance in the 11β-hydroxysteroid dehydrogenase system, higher insulin, increased frequency of glucose/insulin index more than 0.3, γ-glutamyl transpeptidase activity, systolic blood pressure, and tendency to liver steatosis. Cluster 5 (n = 17, 5 females) had elevated dehydroepiandrosterone and 17-OH-pregnenolone metabolites, suggesting 3β-hydroxysteroid dehydrogenase insufficiency but no clinically unique phenotype. Z-score body mass index values were not significantly different between the clusters. CONCLUSIONS: We defined a novel concept of disease-specific steroid metabolomic signature based on urinary steroidal gas chromatography-mass spectrometry. Clustering by software designed for metabolic data analysis reclassified childhood obesity into 5 groups with distinctive signatures; groups require further definition and may require cluster-specific therapeutic strategies.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Gawlik A, Shmoish M, Hartmann MF, et al. Steroid Metabolomic Disease Signature of Nonsyndromic Childhood Obesity. J Clin Endocrinol Metab. 2016. PMID: 27504851

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。